Bacteriostatic Water for Preclinical Injection Research

What USP specifications apply to bacteriostatic water used in preclinical research?

Bacteriostatic water for injection must meet USP monograph standards including sterility per USP <71>, endotoxin limits per USP <85> (typically <0.5 EU/mL for injection-grade water), and pH range of 4.5–7.0. The benzyl alcohol preservative concentration is specified at 0.9% w/v to inhibit bacterial growth in multi-dose vials while remaining compatible with most peptide and protein structures. USP <1> requires that water for injection originate from a source meeting USP Purified Water standards and be sterilized by an approved method such as autoclaving or sterile filtration through a 0.22-micron membrane.

Container closure integrity is governed by USP <1207>, mandating Type I borosilicate glass vials to prevent leachables that could interfere with assay results or compromise study reproducibility. Per-lot testing documentation becomes essential in preclinical GLP studies where regulatory audits require full chain-of-custody for all reagents. Each lot should be traceable to specific manufacturing dates, sterilization parameters, and third-party analytical results confirming absence of particulate matter per USP <788> and meeting compendial limits for heavy metals and chemical contaminants.

How do you calculate injection volumes for preclinical rodent studies using bacteriostatic water?

Injection volume limits for rodent studies depend on route of administration and animal mass: intraperitoneal injections typically allow 10 mL/kg in mice and rats, subcutaneous injections 5–10 mL/kg, and intravenous bolus injections are limited to 5 mL/kg to avoid circulatory overload. For a 25-gram mouse receiving a compound at 10 mg/kg, if your stock solution is 5 mg/mL in bacteriostatic water, you would inject 50 microliters (0.05 mL) intraperitoneally. These volume constraints often dictate the need for concentrated stock solutions, requiring iterative reconstitution calculations to stay within physiologically safe limits.

Benzyl alcohol toxicity becomes a consideration at volumes exceeding 0.06 mL of bacteriostatic water per gram of body weight in neonatal animals, equivalent to approximately 0.5 mg benzyl alcohol per gram. In adult rodents, the LD50 for benzyl alcohol is substantially higher (approximately 1–2 g/kg orally), but repeated daily dosing at high volumes may still produce cumulative preservative exposure. When study protocols require large-volume dilutions or frequent repeat dosing, researchers often prepare working solutions by diluting the reconstituted compound further in sterile saline immediately before injection to minimize benzyl alcohol load per injection event.

What is the difference between bacteriostatic water and sterile water for preclinical injection research?

Bacteriostatic water contains 0.9% benzyl alcohol as a preservative allowing multi-dose withdrawal over 28 days when stored at 2–8°C and handled aseptically, whereas sterile water for injection contains no preservative and must be used as a single-dose product discarded immediately after vial entry. The benzyl alcohol in bacteriostatic water inhibits gram-positive and gram-negative bacterial growth, reducing contamination risk during repeated needle punctures for serial dosing studies. Sterile water is preferred when benzyl alcohol may interfere with the compound's stability or when neonatal animals are subjects, due to immature hepatic metabolism of benzyl alcohol metabolites.

Cost and workflow efficiency favor bacteriostatic water in chronic dosing studies: a single 10 mL vial of bacteriostatic water can reconstitute multiple compound aliquots over weeks, whereas sterile water requires opening a fresh single-use vial for each reconstitution event. This difference compounds in large preclinical studies with 50–100 animals dosed daily. BAC Water Depot's bulk pricing tiers ($6.49 per vial for 500+ units) make bacteriostatic water economically favorable when study timelines extend beyond single-day dosing and when compounds remain stable in the presence of benzyl alcohol for the required storage period.

Maximum safe injection volumes for common preclinical routes of administration in rodents using bacteriostatic water

Key Facts

1. Bacteriostatic water contains 0.9% benzyl alcohol as a preservative to inhibit bacterial growth in multi-dose vials for up to 28 days.
2. USP <71> sterility testing confirms absence of viable microorganisms in each lot of injection-grade bacteriostatic water.
3. Type I borosilicate glass vials minimize leachables that could interfere with analytical assays in preclinical pharmacokinetic studies.
4. BAC Water Depot bacteriostatic water is manufactured in an ISO 9001:2015-registered facility with per-lot third-party testing documentation.
5. Maximum intraperitoneal injection volume for mice and rats using bacteriostatic water is typically 10 mL/kg body weight.